Post by Galderma

Galderma announces the triple approval of its next-generation Restylane® syringe in the EU, the U.S., and Canada.    Developed in collaboration with aesthetic practitioners, the new syringe introduces enhanced ergonomics and improved injection control to support consistent, premium results.    These approvals demonstrate our strong heritage in Injectable Aesthetics, and our continued commitment to driving innovation in the field.    Read more: https://lnkd.in/eVPvwkCr

Video Content